It was shown that in lung cancer, MUC16 mutations can lead to its oncogenic upregulation [34] and the overexpression of MUC16 is associated with increased tumour cell growth, cancer cell migration, and resistance to cytotoxic drugs [35]. The gene discussed is MUC16; the disease is lung cancer.